- Published at
- by stockhead.com.au
mixed
mixed
ASX Health Stocks: Emyria surges another 10pc; cannabis play Vitura delivers record profit
Emyria (ASX:EMD) says it has secured sufficient clinical-grade MDMA to support its MDMA-assisted therapy for over 70 patients.